Genetic Technologies (ASX:GTG) Obtains US, ANZ Distribution Rights of Taliaz’s PREDICTIX

Molecular diagnostics company Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE) has entered into a partnership agreement with Taliaz, a mental health company.

The three-year agreement is for the distribution right of PREDICTIX products in Australia, New Zealand, and the US.

The partnership will support GTG to expand its product offering and establish the mental health vertical by harnessing PREDICTIX.

On 1 December 2020, GTG shares traded at A$0.008 up by 14.285% at 12:34 PM.

Comment


Disclaimer

Ad

GET A FREE STOCK REPORT


Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.


   
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK